Pharmacia Removes Another PCBs Exposure Suit; Multi-Plaintiff Complaint Says Compound Causes Cancer



DOCUMENTS
  • Removal Notice


ST. LOUIS –– Pharmacia LLC has removed another PCBs exposure lawsuit, again maintaining that the compound was manufactured under the direction of the U.S. government, thus invoking federal jurisdiction.

In the April 18 removal notice filed in the U.S. District Court for the Eastern District of Missouri, the defendant removed the multi-plaintiff lawsuit, the latest in a string of complaints involving the defendant’s polychlorinated biphenyls (PCBs).

The nearly 30 plaintiffs in the underlying suit contended that they developed a variety of illnesses –– including non-Hodgkin’s lymphoma, malignant melanoma, and breast cancer –– as a result of exposure to PCBs …






UPCOMING CONFERENCES




HarrisMartin's Webinar Series: Video Game Addiction Product Liability Litigation

March 29, 2024

MORE DETAILS



HarrisMartin's Masters of Mass Tort Settlements Conference - Sponsored by Milestone

June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo

MORE DETAILS